TWO CANCER DRUGS PREVENT, REVERSE TYPE 1 DIABETES, UCSF STUDY SHOWS
November 17, 2008
November 17, 2008
SAN FRANCISCO, Nov. 17 -- The University of California at San Francisco issued the following press release:
Two common cancer drugs have been shown to both prevent and reverse type 1 diabetes in a mouse model of the disease, according to research conducted at the University of California, San Francisco. The drugs - imatinib (marketed as Gleevec) and sunitinib (marketed as Sutent) - were found to put type 1 diabetes into remission in 80 percent of the test mice and work permanently . . .
Two common cancer drugs have been shown to both prevent and reverse type 1 diabetes in a mouse model of the disease, according to research conducted at the University of California, San Francisco. The drugs - imatinib (marketed as Gleevec) and sunitinib (marketed as Sutent) - were found to put type 1 diabetes into remission in 80 percent of the test mice and work permanently . . .